MedTrace Logo

Intraoperative Fluorescence With Augmented Reality

NCT03888014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2023-01-18

No results posted yet for this study

Summary

This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.

Conditions

  • Vascular; Lesion, Central Nervous System
  • Brain Tumor
  • Cerebral Aneurysm
  • Cerebral AVM

Interventions

DEVICE

GLOW800

The treatment group will consist of patients who require a medically necessary craniotomy. If an investigator deems that it will be useful to see blood vessels better with indocyanine green (ICG) videoangiography (VA), patients may be consented for the use if ICG VA using augmented reality (GLOW800). This will not add additional time or risk to their surgery

DRUG

indocyanine green (ICG)

This is a standard medication which can be given IV during a surgery to better visualize blood vessels under the microscope

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-06-01
Completion
2021-06-01
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03888014 on ClinicalTrials.gov